Perrigo Company plc (NYSE:PRGO) Shares Bought by Bahl & Gaynor Inc.

Bahl & Gaynor Inc. increased its position in shares of Perrigo Company plc (NYSE:PRGO) by 44.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,525,197 shares of the company’s stock after buying an additional 472,958 shares during the period. Bahl & Gaynor Inc. owned 1.12% of Perrigo worth $39,213,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently modified their holdings of the business. Versant Capital Management Inc acquired a new stake in shares of Perrigo in the fourth quarter valued at about $45,000. GAMMA Investing LLC lifted its position in shares of Perrigo by 93.7% in the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company’s stock valued at $49,000 after acquiring an additional 929 shares in the last quarter. Central Pacific Bank Trust Division increased its position in shares of Perrigo by 33.3% during the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock worth $51,000 after purchasing an additional 500 shares in the last quarter. Venturi Wealth Management LLC acquired a new position in Perrigo in the 3rd quarter valued at $56,000. Finally, KBC Group NV lifted its stake in shares of Perrigo by 25.1% in the third quarter. KBC Group NV now owns 4,517 shares of the company’s stock worth $118,000 after buying an additional 905 shares in the last quarter. 95.91% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Jeffrey B. Kindler sold 17,598 shares of the business’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $28.27, for a total transaction of $497,495.46. Following the transaction, the director now directly owns 5,409 shares of the company’s stock, valued at approximately $152,912.43. The trade was a 76.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.70% of the company’s stock.

Perrigo Stock Down 0.1 %

Perrigo stock opened at $28.96 on Tuesday. Perrigo Company plc has a twelve month low of $23.14 and a twelve month high of $33.46. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. The stock has a 50 day moving average of $25.00 and a two-hundred day moving average of $26.20. The stock has a market capitalization of $3.95 billion, a price-to-earnings ratio of -24.75 and a beta of 0.54.

Perrigo (NYSE:PRGO) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.92 by $0.01. The firm had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.20 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. As a group, research analysts expect that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Friday, March 7th will be given a dividend of $0.29 per share. The ex-dividend date is Friday, March 7th. This represents a $1.16 dividend on an annualized basis and a yield of 4.01%. This is a positive change from Perrigo’s previous quarterly dividend of $0.28. Perrigo’s dividend payout ratio (DPR) is -92.80%.

Analyst Upgrades and Downgrades

PRGO has been the subject of a number of recent research reports. StockNews.com downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Piper Sandler cut Perrigo from an “overweight” rating to a “neutral” rating and dropped their target price for the company from $34.00 to $27.00 in a report on Monday, January 6th. Finally, Argus cut Perrigo from a “buy” rating to a “hold” rating in a report on Tuesday, January 14th. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, Perrigo has a consensus rating of “Hold” and a consensus target price of $33.00.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.